{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:57:35Z","timestamp":1793429855264,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11060-018-03005-x","type":"journal-article","created":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T16:07:44Z","timestamp":1543680464000},"page":"83-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients"],"prefix":"10.1007","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4279-4497","authenticated-orcid":false,"given":"Oliver","family":"Grauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Hess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Weckesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Schwindt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Maring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"W\u00f6lfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Stummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,1]]},"reference":[{"key":"3005_CR1","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3109\/02656739609027678","volume":"12","author":"A Jordan","year":"1996","unstructured":"Jordan A, Wust P, Scholz R, Tesche B, Fahling H, Mitrovics T, Vogl T, Cervos-Navarro J, Felix R (1996) Cellular uptake of magnetic fluid particles and their effects on human adenocarcinoma cells exposed to AC magnetic fields in vitro. Int J Hyperth 12:705\u2013722","journal-title":"Int J Hyperth"},{"key":"3005_CR2","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3109\/02656739709023559","volume":"13","author":"A Jordan","year":"1997","unstructured":"Jordan A, Scholz R, Wust P, Fahling H, Krause J, Wlodarczyk W, Sander B, Vogl T, Felix R (1997) Effects of magnetic fluid hyperthermia (MFH) on C3H mammary carcinoma in vivo. Int J Hyperth 13:587\u2013605","journal-title":"Int J Hyperth"},{"key":"3005_CR3","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0304-8853(98)00558-7","volume":"194","author":"A Jordan","year":"1999","unstructured":"Jordan A, Scholz R, Wust P, Schirra H, Schiestel T, Schmidt H, Felix R (1999) Endocytosis of dextran and silan-coated magnetite nanoparticles and the effect of intracellular hyperthermia on human mammary carcinoma cells in vitro. J Magn Magn Mater 194:185\u2013196","journal-title":"J Magn Magn Mater"},{"key":"3005_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1089\/0892779041271715","volume":"18","author":"M Johannsen","year":"2004","unstructured":"Johannsen M, Jordan A, Scholz R, Koch M, Lein M, Deger S, Roigas J, Jung K, Loening S (2004) Evaluation of magnetic fluid hyperthermia in a standard rat model of prostate cancer. J Endourol 18:495\u2013500","journal-title":"J Endourol"},{"key":"3005_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/pros.20213","volume":"64","author":"M Johannsen","year":"2005","unstructured":"Johannsen M, Thiesen B, Jordan A, Taymoorian K, Gneveckow U, Waldofner N, Scholz R, Koch M, Lein M, Jung K, Loening SA (2005) Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model. Prostate 64:283\u2013292","journal-title":"Prostate"},{"key":"3005_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11060-005-9059-z","volume":"78","author":"A Jordan","year":"2006","unstructured":"Jordan A, Scholz R, Maier-Hauff K, van Landeghem FK, Waldoefner N, Teichgraeber U, Pinkernelle J, Bruhn H, Neumann F, Thiesen B, von Deimling A, Felix R (2006) The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J Neurooncol 78:7\u201314","journal-title":"J Neurooncol"},{"key":"3005_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/pros.20324","volume":"66","author":"M Johannsen","year":"2006","unstructured":"Johannsen M, Thiesen B, Gneveckow U, Taymoorian K, Waldofner N, Scholz R, Deger S, Jung K, Loening SA, Jordan A (2006) Thermotherapy using magnetic nanoparticles combined with external radiation in an orthotopic rat model of prostate cancer. Prostate 66:97\u2013104","journal-title":"Prostate"},{"key":"3005_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1349-7006.1998.tb03283.x","volume":"89","author":"M Yanase","year":"1998","unstructured":"Yanase M, Shinkai M, Honda H, Wakabayashi T, Yoshida J, Kobayashi T (1998) Antitumor immunity induction by intracellular hyperthermia using magnetite cationic liposomes. Jpn J Cancer Res 89:775\u2013782","journal-title":"Jpn J Cancer Res"},{"key":"3005_CR9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00262-002-0335-x","volume":"52","author":"A Ito","year":"2003","unstructured":"Ito A, Shinkai M, Honda H, Yoshikawa K, Saga S, Wakabayashi T, Yoshida J, Kobayashi T (2003) Heat shock protein 70 expression induces antitumor immunity during intracellular hyperthermia using magnetite nanoparticles. Cancer Immunol Immunother 52:80\u201388","journal-title":"Cancer Immunol Immunother"},{"key":"3005_CR10","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/ijc.21061","volume":"116","author":"K Tanaka","year":"2005","unstructured":"Tanaka K, Ito A, Kobayashi T, Kawamura T, Shimada S, Matsumoto K, Saida T, Honda H (2005) Intratumoral injection of immature dendritic cells enhances antitumor effect of hyperthermia using magnetic nanoparticles. Int J Cancer 116:624\u2013633","journal-title":"Int J Cancer"},{"key":"3005_CR11","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.ijrobp.2003.09.012","volume":"58","author":"S Demaria","year":"2004","unstructured":"Demaria S, Ng B, Devitt ML, Babb JS, Kawashima N, Liebes L, Formenti SC (2004) Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated. Int J Radiat Oncol Biol Phys 58:862\u2013870","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3005_CR12","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/j.1349-7006.2003.tb01438.x","volume":"94","author":"A Ito","year":"2003","unstructured":"Ito A, Tanaka K, Kondo K, Shinkai M, Honda H, Matsumoto K, Saida T, Kobayashi T (2003) Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma. Cancer Sci 94:308\u2013313","journal-title":"Cancer Sci"},{"key":"3005_CR13","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2217\/nnm.12.142","volume":"8","author":"A Ito","year":"2013","unstructured":"Ito A, Yamaguchi M, Okamoto N, Sanematsu Y, Kawabe Y, Wakamatsu K, Ito S, Honda H, Kobayashi T, Nakayama E, Tamura Y, Okura M, Yamashita T, Jimbow K, Kamihira M (2013) T-cell receptor repertoires of tumor-infiltrating lymphocytes after hyperthermia using functionalized magnetite nanoparticles. Nanomedicine (Lond) 8:891\u2013902","journal-title":"Nanomedicine (Lond)"},{"key":"3005_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11060-006-9195-0","volume":"81","author":"K Maier-Hauff","year":"2007","unstructured":"Maier-Hauff K, Rothe R, Scholz R, Gneveckow U, Wust P, Thiesen B, Feussner A, von Deimling A, Waldoefner N, Felix R, Jordan A (2007) Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J Neurooncol 81:53\u201360","journal-title":"J Neurooncol"},{"key":"3005_CR15","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11060-010-0389-0","volume":"103","author":"K Maier-Hauff","year":"2011","unstructured":"Maier-Hauff K, Ulrich F, Nestler D, Niehoff H, Wust P, Thiesen B, Orawa H, Budach V, Jordan A (2011) Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol 103:317\u2013324","journal-title":"J Neurooncol"},{"key":"3005_CR16","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.biomaterials.2008.09.044","volume":"30","author":"FK Landeghem van","year":"2009","unstructured":"van Landeghem FK, Maier-Hauff K, Jordan A, Hoffmann KT, Gneveckow U, Scholz R, Thiesen B, Bruck W, von Deimling A (2009) Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticles. Biomaterials 30:52\u201357","journal-title":"Biomaterials"},{"key":"3005_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/02656730600734128","volume":"22","author":"M Plotkin","year":"2006","unstructured":"Plotkin M, Gneveckow U, Meier-Hauff K, Amthauer H, Feussner A, Denecke T, Gutberlet M, Jordan A, Felix R, Wust P (2006) 18F-FET PET for planning of thermotherapy using magnetic nanoparticles in recurrent glioblastoma. Int J Hyperthermia 22:319\u2013325","journal-title":"Int J Hyperthermia"},{"key":"3005_CR18","first-page":"586","volume":"85","author":"TS Yoo","year":"2002","unstructured":"Yoo TS, Ackerman MJ, Lorensen WE, Schroeder W, Chalana V, Aylward S, Metaxas D, Whitaker R (2002) Engineering and algorithm design for an image processing API: a technical report on ITK\u2014the Insight Toolkit. Stud Health Technol Inform 85:586\u2013592","journal-title":"Stud Health Technol Inform"},{"key":"3005_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1118\/1.1748629","volume":"31","author":"U Gneveckow","year":"2004","unstructured":"Gneveckow U, Jordan A, Scholz R, Bruss V, Waldofner N, Ricke J, Feussner A, Hildebrandt B, Rau B, Wust P (2004) Description and characterization of the novel hyperthermia- and thermoablation-system MFH 300F for clinical magnetic fluid hyperthermia. Med Phys 31:1444\u20131451","journal-title":"Med Phys"},{"key":"3005_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1040-8428(01)00179-2","volume":"43","author":"B Hildebrandt","year":"2002","unstructured":"Hildebrandt B, Wust P, Ahlers O, Dieing A, Sreenivasa G, Kerner T, Felix R, Riess H (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43:33\u201356","journal-title":"Crit Rev Oncol Hematol"},{"key":"3005_CR21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1748-717X-2-26","volume":"2","author":"CD Fuller","year":"2007","unstructured":"Fuller CD, Choi M, Forthuber B, Wang SJ, Rajagiriyil N, Salter BJ, Fuss M (2007) Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme. Radiat Oncol 2:26","journal-title":"Radiat Oncol"},{"key":"3005_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.radonc.2015.12.003","volume":"118","author":"M Niyazi","year":"2016","unstructured":"Niyazi M, Brada M, Chalmers AJ, Combs SE, Erridge SC, Fiorentino A, Grosu AL, Lagerwaard FJ, Minniti G, Mirimanoff RO, Ricardi U, Short SC, Weber DC, Belka C (2016) ESTRO-ACROP guideline \u201ctarget delineation of glioblastomas\u201d. Radiother Oncol 118:35\u201342","journal-title":"Radiother Oncol"},{"key":"3005_CR23","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.21873\/anticanres.11067","volume":"36","author":"C Nieder","year":"2016","unstructured":"Nieder C, Andratschke NH, Grosu AL (2016) Re-irradiation for recurrent primary brain tumors. Anticancer Res 36:4985\u20134995","journal-title":"Anticancer Res"},{"key":"3005_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13014-017-0928-3","volume":"12","author":"AV Krauze","year":"2017","unstructured":"Krauze AV, Attia A, Braunstein S, Chan M, Combs SE, Fietkau R, Fiveash J, Flickinger J, Grosu A, Howard S, Nieder C, Niyazi M, Rowe L, Smart DD, Tsien C, Camphausen K (2017) Expert consensus on re-irradiation for recurrent glioma. Radiat Oncol 12:194","journal-title":"Radiat Oncol"},{"key":"3005_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1159\/000364943","volume":"53","author":"J Schroeteler","year":"2014","unstructured":"Schroeteler J, Reeker R, Suero Molina E, Brokinkel B, Holling M, Grauer OM, Senner V, Stummer W, Ewelt C (2014) Glioma tissue obtained by modern ultrasonic aspiration with a simple sterile suction trap for primary cell culture and pathological evaluation. Eur Surg Res 53:37\u201342","journal-title":"Eur Surg Res"},{"key":"3005_CR26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ijc.22607","volume":"121","author":"OM Grauer","year":"2007","unstructured":"Grauer OM, Nierkens S, Bennink E, Toonen LW, Boon L, Wesseling P, Sutmuller RP, Adema GJ (2007) CD4 + FoxP3 + regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. Int J Cancer 121:95\u2013105","journal-title":"Int J Cancer"},{"key":"3005_CR27","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1215\/15228517-2008-104","volume":"11","author":"JF Jacobs","year":"2009","unstructured":"Jacobs JF, Idema AJ, Bol KF, Nierkens S, Grauer OM, Wesseling P, Grotenhuis JA, Hoogerbrugge PM, de Vries IJ, Adema GJ (2009) Regulatory T cells and the PD-L1\/PD-1 pathway mediate immune suppression in malignant human brain tumors. Neuro Oncol 11:394\u2013402","journal-title":"Neuro Oncol"},{"key":"3005_CR28","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/neuonc\/nov280","volume":"18","author":"D Dubinski","year":"2016","unstructured":"Dubinski D, Wolfer J, Hasselblatt M, Schneider-Hohendorf T, Bogdahn U, Stummer W, Wiendl H, Grauer OM (2016) CD4 + T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients. Neuro Oncol 18:807\u2013818","journal-title":"Neuro Oncol"},{"issue":"2","key":"3005_CR29","doi-asserted-by":"publisher","first-page":"Pii:e85841","DOI":"10.1172\/jci.insight.85841","volume":"1","author":"K Gabrusiewicz","year":"2016","unstructured":"Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A, Liebelt BD, Yaghi NK, Ezhilarasan R, Huang N, Weinberg JS, Prabhu SS, Rao G, Sawaya R, Langford LA, Bruner JM, Fuller GN, Bar-Or A, Li W, Colen RR, Curran MA, Bhat KP, Antel JP, Cooper LJ, Sulman EP, Heimberger AB (2016) Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight 1(2):Pii:e85841","journal-title":"JCI Insight"},{"key":"3005_CR30","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.wneu.2018.04.016","volume":"115","author":"VM Lu","year":"2018","unstructured":"Lu VM, Jue TR, McDonald KL, Rovin RA (2018) The survival effect of repeat surgery at glioblastoma recurrence and its trend: a systematic review and meta-analysis. World Neurosurg 115:453\u2013459","journal-title":"World Neurosurg"},{"key":"3005_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0360-3016(97)00731-1","volume":"40","author":"PK Sneed","year":"1998","unstructured":"Sneed PK, Stauffer PR, McDermott MW, Diederich CJ, Lamborn KR, Prados MD, Chang S, Weaver KA, Spry L, Malec MK, Lamb SA, Voss B, Davis RL, Wara WM, Larson DA, Phillips TL, Gutin PH (1998) Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +\/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:287\u2013295","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3005_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/1748-717X-9-89","volume":"9","author":"Y Rubner","year":"2014","unstructured":"Rubner Y, Muth C, Strnad A, Derer A, Sieber R, Buslei R, Frey B, Fietkau R, Gaipl US (2014) Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines. Radiat Oncol 9:89","journal-title":"Radiat Oncol"},{"key":"3005_CR33","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/S0360-3016(99)00336-3","volume":"45","author":"KH Cho","year":"1999","unstructured":"Cho KH, Hall WA, Gerbi BJ, Higgins PD, McGuire WA, Clark HB (1999) Single dose versus fractionated stereotactic radiotherapy for recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys 45:1133\u20131141","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3005_CR34","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11060-004-2463-y","volume":"74","author":"SE Combs","year":"2005","unstructured":"Combs SE, Gutwein S, Thilmann C, Huber P, Debus J, Schulz-Ertner D (2005) Stereotactically guided fractionated re-irradiation in recurrent glioblastoma multiforme. J Neurooncol 74:167\u2013171","journal-title":"J Neurooncol"},{"key":"3005_CR35","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1007\/s11060-008-9607-4","volume":"89","author":"SE Combs","year":"2008","unstructured":"Combs SE, Bischof M, Welzel T, Hof H, Oertel S, Debus J, Schulz-Ertner D (2008) Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas. J Neurooncol 89:205\u2013210","journal-title":"J Neurooncol"},{"key":"3005_CR36","doi-asserted-by":"publisher","first-page":"e8293","DOI":"10.1097\/MD.0000000000008293","volume":"96","author":"K Fetcko","year":"2017","unstructured":"Fetcko K, Lukas RV, Watson GA, Zhang L, Dey M (2017) Survival and complications of stereotactic radiosurgery: a systematic review of stereotactic radiosurgery for newly diagnosed and recurrent high-grade gliomas. Medicine (Baltimore) 96:e8293","journal-title":"Medicine (Baltimore)"},{"key":"3005_CR37","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1148\/123.2.463","volume":"123","author":"WC Dewey","year":"1977","unstructured":"Dewey WC, Hopwood LE, Sapareto SA, Gerweck LE (1977) Cellular responses to combinations of hyperthermia and radiation. Radiology 123:463\u2013474","journal-title":"Radiology"},{"key":"3005_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1139\/O08-136","volume":"86","author":"A Bettaieb","year":"2008","unstructured":"Bettaieb A, Averill-Bates DA (2008) Thermotolerance induced at a fever temperature of 40 degrees C protects cells against hyperthermia-induced apoptosis mediated by death receptor signalling. Biochem Cell Biol 86:521\u2013538","journal-title":"Biochem Cell Biol"},{"key":"3005_CR39","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1073\/pnas.0405193102","volume":"102","author":"D Lau","year":"2005","unstructured":"Lau D, Mollnau H, Eiserich JP, Freeman BA, Daiber A, Gehling UM, Brummer J, Rudolph V, Munzel T, Heitzer T, Meinertz T, Baldus S (2005) Myeloperoxidase mediates neutrophil activation by association with CD11b\/CD18 integrins. Proc Natl Acad Sci USA 102:431\u2013436","journal-title":"Proc Natl Acad Sci USA"},{"key":"3005_CR40","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/j.1750-3639.2009.00315.x","volume":"19","author":"OM Grauer","year":"2009","unstructured":"Grauer OM, Wesseling P, Adema GJ (2009) Immunotherapy of diffuse gliomas: biological background, current status and future developments. Brain Pathol 19:674\u2013693","journal-title":"Brain Pathol"},{"key":"3005_CR41","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX (2013) Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol 14:1014\u20131022","journal-title":"Nat Immunol"},{"key":"3005_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1007\/s00262-005-0049-y","volume":"55","author":"A Ito","year":"2006","unstructured":"Ito A, Honda H, Kobayashi T (2006) Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of \u201cheat-controlled necrosis\u201d with heat shock protein expression. Cancer Immunol Immunother 55:320\u2013328","journal-title":"Cancer Immunol Immunother"},{"key":"3005_CR43","first-page":"171","volume":"7","author":"M Shevtsov","year":"2016","unstructured":"Shevtsov M, Multhoff G (2016) Heat shock protein-peptide and HSP-based immunotherapies for the treatment of cancer. Front Immunol 7:171","journal-title":"Front Immunol"},{"key":"3005_CR44","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1158\/1078-0432.CCR-03-0683","volume":"10","author":"SW Krause","year":"2004","unstructured":"Krause SW, Gastpar R, Andreesen R, Gross C, Ullrich H, Thonigs G, Pfister K, Multhoff G (2004) Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial. Clin Cancer Res 10:3699\u20133707","journal-title":"Clin Cancer Res"},{"key":"3005_CR45","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fimmu.2015.00162","volume":"6","author":"HM Specht","year":"2015","unstructured":"Specht HM, Ahrens N, Blankenstein C, Duell T, Fietkau R, Gaipl US, Gunther C, Gunther S, Habl G, Hautmann H, Hautmann M, Huber RM, Molls M, Offner R, Rodel C, Rodel F, Schutz M, Combs SE, Multhoff G (2015) Heat shock protein 70 (Hsp70) peptide activated natural killer (NK) cells for the treatment of patients with non-small cell lung cancer (NSCLC) after radiochemotherapy (RCTx)\u2014from preclinical studies to a clinical phase II trial. Front Immunol 6:162","journal-title":"Front Immunol"},{"key":"3005_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/02656730802104757","volume":"24","author":"B Thiesen","year":"2008","unstructured":"Thiesen B, Jordan A (2008) Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperth 24:467\u2013474","journal-title":"Int J Hyperth"},{"key":"3005_CR47","first-page":"1119","volume":"355","author":"J Zee van der","year":"2000","unstructured":"van der Zee J, Gonzalez D, van Rhoon GC, van Dijk JD, van Putten WL, Hart AA (2000) Comparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trial. Dutch Deep Hyperth Group Lancet 355:1119\u20131125","journal-title":"Dutch Deep Hyperth Group Lancet"},{"key":"3005_CR48","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S1470-2045(10)70071-1","volume":"11","author":"RD Issels","year":"2010","unstructured":"Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC, Abdel-Rahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic Z, Wessalowski R, Jauch KW, Durr HR, Ploner F, Baur-Melnyk A, Mansmann U, Hiddemann W, Blay JY, Hohenberger P (2010) Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. Lancet Oncol 11:561\u2013570","journal-title":"Lancet Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-03005-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-03005-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-03005-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T08:25:50Z","timestamp":1605515150000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-03005-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["3005"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-03005-x","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,1]]},"assertion":[{"value":"22 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"O. Grauer and M. Jaber have received financial support for attending symposia from MagForce AG. W. Stummer has received honoraria for advisory board activities from MagForce AG. All other authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}